| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. | Clin Cancer Res | 2012 | 1.05 |
| 2 | MiR-SNPs as markers of toxicity and clinical outcome in Hodgkin lymphoma patients. | PLoS One | 2013 | 0.88 |
| 3 | Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide. | Leuk Res | 2011 | 0.84 |
| 4 | Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib. | Leuk Res | 2013 | 0.80 |